| Taria Cameron, CCC-SLP | |
|
14130 23rd Ave N, Plymouth, MN 55447 | |
| (763) 383-7666 | |
| (763) 383-6013 |
| Full Name | Taria Cameron |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 14130 23rd Ave N, Plymouth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215532502 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Minnesota) | Secondary |
| 235Z00000X | Speech-language Pathologist | 528497 (Minnesota) | Primary |
| Provider Name | Therapy Junction |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184958704 PECOS PAC ID: 0749508133 Enrollment ID: O20150415000898 |
News Archive
Attagene Inc., a leader in developing innovative technologies for analyzing gene regulatory pathways, announced today the online publication of a paper in Chemical Research in Toxicology, a journal of the American Chemical Society, that highlights results of their collaborative work with the Environmental Protection Agency's National Center for Computational Toxicology (NCCT).
"A measles epidemic has affected tens of thousands of children in northern Democratic Republic of Congo (DRC), overwhelming health facilities, says medical charity Médecins Sans Frontières (MSF)," IRIN reports.
Researchers who collect genetic samples from children for medical research need to explain the process more clearly to parents, according to a new study that suggests many parents don't fully understand the finer details about how these samples will be used and stored. The study was published in June in Genetics in Medicine.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.
Today's health policy headlines include news about some little-known health reform provisions and how the Obama administration is using technology to help consumers navigate changes resulting from the health overhaul.
› Verified 8 days ago
| Provider Name | Empowered By Speech Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114624822 PECOS PAC ID: 6901262476 Enrollment ID: O20230525002790 |
News Archive
Attagene Inc., a leader in developing innovative technologies for analyzing gene regulatory pathways, announced today the online publication of a paper in Chemical Research in Toxicology, a journal of the American Chemical Society, that highlights results of their collaborative work with the Environmental Protection Agency's National Center for Computational Toxicology (NCCT).
"A measles epidemic has affected tens of thousands of children in northern Democratic Republic of Congo (DRC), overwhelming health facilities, says medical charity Médecins Sans Frontières (MSF)," IRIN reports.
Researchers who collect genetic samples from children for medical research need to explain the process more clearly to parents, according to a new study that suggests many parents don't fully understand the finer details about how these samples will be used and stored. The study was published in June in Genetics in Medicine.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.
Today's health policy headlines include news about some little-known health reform provisions and how the Obama administration is using technology to help consumers navigate changes resulting from the health overhaul.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Taria Cameron, CCC-SLP 14130 23rd Ave N, Plymouth, MN 55447 Ph: (763) 383-7666 | Taria Cameron, CCC-SLP 14130 23rd Ave N, Plymouth, MN 55447 Ph: (763) 383-7666 |
News Archive
Attagene Inc., a leader in developing innovative technologies for analyzing gene regulatory pathways, announced today the online publication of a paper in Chemical Research in Toxicology, a journal of the American Chemical Society, that highlights results of their collaborative work with the Environmental Protection Agency's National Center for Computational Toxicology (NCCT).
"A measles epidemic has affected tens of thousands of children in northern Democratic Republic of Congo (DRC), overwhelming health facilities, says medical charity Médecins Sans Frontières (MSF)," IRIN reports.
Researchers who collect genetic samples from children for medical research need to explain the process more clearly to parents, according to a new study that suggests many parents don't fully understand the finer details about how these samples will be used and stored. The study was published in June in Genetics in Medicine.
Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.
Today's health policy headlines include news about some little-known health reform provisions and how the Obama administration is using technology to help consumers navigate changes resulting from the health overhaul.
› Verified 8 days ago
Kristyne Bazinet, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Fernbrook Ln N Ste 138, Plymouth, MN 55447 Phone: 952-544-0349 | |
Kari Shoemaker, M.S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5855 Cheshire Parkway, Plymouth, MN 55446 Phone: 763-553-7600 | |
Amber J Bartlett, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 14130 23rd Ave N, Plymouth, MN 55447 Phone: 763-383-7666 Fax: 763-383-6013 | |
Megan Stumpf, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 15600 36th Ave N Ste 120, Plymouth, MN 55446 Phone: 763-595-0812 Fax: 763-595-0824 | |
Megan L Wroblewski, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3021 Harbor Ln N Ste 120, Plymouth, MN 55447 Phone: 763-551-3652 | |
Eric William Ernest, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14425 8th Ave N, Plymouth, MN 55447 Phone: 763-607-2091 Fax: 763-550-1633 | |
Anne R Lindgren, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 Harbor Ln N, Suite 120, Plymouth, MN 55447 Phone: 763-551-3652 Fax: 763-551-1334 |